RTW Biotech Opportunities Ltd Notice of AGM
18 Aprile 2024 - 10:30AM
RNS Regulatory News
RNS Number : 1584L
RTW Biotech Opportunities Ltd
18 April 2024
LEI: 549300Q7EXQQH6KF7Z84
18 April 2024
RTW Biotech Opportunities
Ltd
(the "Company")
Notice of Annual General
Meeting
RTW Biotech Opportunities
Ltd announces that its Annual General Meeting ("AGM") will be held at 1st
Floor Royal Chambers, St Julian's Avenue St Peter Port,
Guernsey on 16 May 2024 at 2pm BST. The Notice of
AGM was dispatched to all shareholders on 17 April 2024.
A copy of the Notice of AGM has been
submitted to the National Storage Mechanism and will shortly be
available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
The Notice of AGM may also be viewed on the
Company's website at www.rtwfunds.com/rtw-biotech-opportunities-ltd
The Annual Report and Audited
Financial Statements for the year ended 31 December
2023 (the "Annual
Report") is also available on the
Company's website at www.rtwfunds.com/rtw-biotech-opportunities-ltd
You
will not have received a hard copy proxy form for the AGM in the
post. You can instead submit your proxy vote electronically by
accessing the shareholder portal at
www.signalshares.com, logging in and
selecting the 'Vote Online Now' link. Full details of how to vote
are set out in the Notes to the Notice of Meeting. Please submit
your proxy vote so as to reach the Company's registrar as soon as
possible and in any event no later than 2pm BST on 14 May 2024 or,
if you are a CREST member, by using the service provided by
Euroclear. Shares held on your
behalf by a broker or nominee must be voted by the broker, per your
instructions, and cannot be voted at www.signalshares.com.
The completion of the form of proxy will not preclude a member from
attending and voting in person at the meeting if it is so
allowed.
If any shareholder has questions
related to the business of the AGM, please submit your queries
to biotechopportunities@rtwfunds.com
by 2pm BST on 14 May 2024. We will endeavour
to answer every shareholder question and responses will be posted
on the Company's website after the AGM.
For
Further Information
RTW
Investments, LP
|
+44
20 7959 6361
|
Woody Stileman, Managing Director,
Business Development
Krisha McCune, Director, Investor
Relations
|
biotechopportunities@rtwfunds.com
|
|
|
Buchanan (PR & Communications Adviser)
|
+44
20 7466 5107
|
Charles Ryland
|
|
Henry Wilson
|
|
George Beale
|
|
|
|
Deutsche Numis (Joint Corporate Broker)
|
+44
20 7260 1000
|
Freddie Barnfield
|
|
Nathan Brown
|
|
Euan Brown
|
|
|
|
BofA Securities (Joint Corporate Broker)
|
+44
20 7628 1000
|
Edward Peel
|
|
Alex Penney
|
|
Cadarn Capital (Distribution & IR
Partner)
|
+44
73 6888 3211
|
David Harris
|
|
Elysium Fund Management Limited
Joanna Duquemin Nicolle, Chief
Executive Officer
Sadie Morrison, Managing
Director
|
+44
14 8181 0100
|
Morgan Stanley Fund Services USA LLC
|
+1
914 225 8885
|
About Biotech Opportunities Ltd:
RTW Biotech Opportunities Ltd (LSE:
RTW & RTWG) is an investment fund focused on identifying
transformative assets with high growth potential across the
biopharmaceutical and medical technology sectors. Driven by a
long-term approach to support innovative businesses, RTW Biotech
Opportunities Ltd invests in companies developing next-generation
therapies and technologies that can significantly improve patients'
lives. RTW Biotech Opportunities Ltd is managed by RTW Investments,
LP, a leading healthcare-focused
entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the website
at www.rtwfunds.com/rtw-biotech-opportunities-ltd for
more information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NOAEAXLPFDLLEEA
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Mag 2023 a Mag 2024